LVLavanya Vijayasingham

Lavanya Vijayasingham

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lavanya Vijayasingham has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrating noncommunicable disease care in a public primary health care facility in North Lebanon: A qualitative study of implementation in a humanitarian crisis

    by Linda Abou-Abbas, Lavanya Vijayasingham, Carla Zmeter, Aya El Khatib, Grace Abou Nakad, Leah Anku Sanga, Randa S. Hamadeh, Pablo Perel, Sigiriya Aebischer Perone, Éimhín M. Ansbro

    Integrated care for non-communicable diseases (NCDs) may enhance care delivery, clinical impact, user-satisfaction, and access. However, evidence on integrated NCD care in humanitarian settings remains scarce. This qualitative study accompanied the first year of implementation (March 2023 to March 2024) of an integrated care programme at an International Committee of the Red Cross (ICRC)-supported, Ministry of Public Health-affiliated primary healthcare centre (PHC) in North Lebanon. A preceding theory of change (TOC) workshop on combining NCD PHC, mental health and psychosocial support (MPHSS), and rehabilitation services, identified two interdependent pathways to integrated NCD care: the multidisciplinary service pathway and the patient/family support pathway. The REAIM PRISM implementation science framework guided the study design, analysis and reporting. We interviewed service users and ICRC/PHC staff and analysed interview data alongside programme documentation using a joint thematic and constructive grounded theory approach. Overall, integrated care was feasible despite contextual challenges, including economic crisis, job losses, regional tensions, and insufficient NCD financing. A key overarching theme emerged: staff-related human values, motivation, and work ethic driving action amid personal and professional adversity. Implementation narratives described assimilating new processes, adapting to contextual challenges, and resolving process-oriented problems. In the first year, interventions under the TOC’s multidisciplinary pathway—such as training, streamlined processes, and improved data systems—were prioritized, notably incorporating MHPSS and diabetic foot screening, while interventions in the patient empowerment pathway were not yet implemented. PHC NCD care remained the entry point for integrated care with unidirectional referrals to collocated services. Most service users reported no change in their clinic experience; however, many positively noted improvements in programme quality, respect, and trust. Limited awareness or demand for MHPSS services was observed. Strengthening bidirectional referrals, multidisciplinary meetings, patient and caregiver empowerment, and promotion of self-care may address unmet needs and promote uptake of MHPSS and rehabilitation services.

  • Open Access

    People with lived experience of chronic conditions are key epistemic authorities in global health

    by Lavanya Vijayasingham, Mansi Chopra, Edith Mukantwari, Benny Prawira, Eman Shannan, Joab Wako, Maria Divina O'BRien, Mark Barone


  • Open Access

    Challenges in accessing health care services for women and girls with disabilities using a humanitarian physical rehabilitation program in Lebanon: a mixed method study

    by Linda Abou-Abbas, Diana Sabbagh, Rodolfo Rossi, Lavanya Vijayasingham, Maria Rita Lteif, Haya Rawi, Rouba Mitri, Hala Al Sultan, Aicha Benyaich, Ahmad Al-Mosa, et al.

    Achieving equitable healthcare access for persons with disabilities is vital, as they often face various barriers that impact their health and well-being. Recognizing the importance of gender equity, this study aims to explore the specific barriers faced by women and girls with disabilities in accessing quality healthcare services in Lebanon. A mixed-method sequential explanatory approach was employed. Initially, a retrospective descriptive study analyzed data from the International Committee of the Red Cross (ICRC)-supported physical rehabilitation programme (PRP) database. Subsequently, in-depth interviews were conducted to delve into factors influencing gender-disproportionate service users and to uncover barriers to accessing healthcare. Levesque et al.‘s ‘Conceptual framework on healthcare access’ was used to organize and map the results. The quantitative analysis of service utilization at ICRC PRP centers from 2015 to 2022 revealed significant gender disparities, with males comprising 66.6% of service users compared to 33.4% females. This trend was consistent across age categories, nationalities, and clinical conditions. Healthcare access for women and girls with disabilities was found to be inadequate across all five dimensions of the Levesque framework: adequacy, accessibility, affordability, appropriateness, and availability, as well as their corresponding abilities. While certain challenges such as transportation, financial constraints, inadequate infrastructure, and limited information on available services were common to both genders, gender-specific barriers primarily included societal norms, safety concerns during unaccompanied visits to healthcare facilities, limited access to societal information, economic disparities, preferences for female healthcare providers, and the need for privacy during consultations. This study underscores key barriers hindering healthcare access for women and girls with disabilities in Lebanon, necessitating tailored interventions. Gender-specific challenges, including societal norms and safety concerns, require targeted solutions for improved access and outcomes. This study serves as a call to action for stakeholders at various levels to collaborate and implement concrete measures to bridge the gap in healthcare access and ensure that no one is left behind.


  • Open Access

    Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations

    by Martina Mchenga, Lavanya Vijayasingham, Rajalakshmi RamPrakash, Michelle Remme

    Economic evaluations play a crucial role in health resource allocation by assessing the costs and effects of various interventions. However, existing methodologies often overlook significant differences related to sex and gender, leading to a ‘blind spot’ in understanding patient heterogeneity. This paper highlights how biological and social factors influence costs and health outcomes differently for women, emphasising the need for a more explicit consideration of these differences in economic evaluations to ensure efficient and equitable resource allocation. The paper is structured to first outline how sex and gender factors impact costs and outcomes. It then identifies biases in current economic evaluation methods and practices, using real-world examples to illustrate the implications of these biases on policymaking and health equity. Notably, we argue that neglecting gender considerations can lead to inefficiencies and inequities in healthcare resource distribution. Key areas of gender bias include the estimation of productivity losses, quality of life variations and the secondary household effects of interventions. The analysis reveals that women often face higher healthcare costs and experience different health outcomes due to systemic biases in treatment and care. The paper concludes with practical recommendations for analysts, decision makers and research funders, advocating for the integration of sex and gender-responsive methodologies in health economic evaluations. Ultimately, this work calls for a paradigm shift in health economics to better reflect the complexities of sex and gender and improve health outcomes for all.


  • Open Access

    Living with and managing type 1 diabetes in humanitarian settings: A qualitative synthesis of lived experience and stakeholder tacit knowledge

    by Oria James, Linda Abbou-Abbas, Lavanya Vijayasingham

    Humanitarian health actors are beginning to better consider and manage non-communicable diseases, such as diabetes, in emergency and protracted crisis settings. However, a focus on the more globally prevalent type 2 diabetes (T2D) dominates. Blind spots prevail in the unmet needs for type 1 diabetes (T1D), a chronic autoimmune condition where individuals are unable to produce insulin, thereby dependent on lifelong insulin therapy and blood glucose management. Although some T1D management requirements overlap with those of T2D, the immediate risk of fatal complications following insulin therapy disruption, the earlier age of onset during childhood, adolescence or young adulthood, and its lower prevalence compared to T2D within communities and local health systems mean that T1D requires nuanced consideration and targeted interventions. Intending to inform program and policy design for people with T1D (PWT1D), we synthesized themes of lived experience from PLWT1D and their caregivers, and the tacit working knowledge of health providers and policymakers in the context of local humanitarian operations. Through a strategic search of health databases (up to July 2023), we identified 11 articles that include interview excerpts from PWT1D, caregivers, healthcare providers and policymakers about T1D management in humanitarian settings. We used reflexive thematic analysis to guide data extraction, coding, and synthesis, resulting in the identification of four overarching themes: food and insulin security, family relations, knowledge translation, and response to diagnosis. The narratives highlight harsh trade-offs made by PWT1D and their families in the face of insulin and food insecurity, as well as the damaging impact of low T1D education in families, communities and health systems. Targeted family and community-based solutions are urgently required, alongside systemic reforms and international collaboration to enable better T1D coping and management in humanitarian settings.


  • Open Access

    A shared agenda for gender and COVID-19 research: priorities based on broadening engagement in science

    by Asha S. George, Claudia A. Lopes, Lavanya Vijayasingham, Mamothena Carol Mothupi, Ronald Musizvingoza, Gita Mishra, Jacqui Stevenson, Michelle Remme

    While the acute and collective crisis from the pandemic is over, an estimated 2.5 million people died from COVID-19 in 2022, tens of millions suffer from long COVID and national economies still reel from multiple deprivations exacerbated by the pandemic. Sex and gender biases deeply mark these evolving experiences of COVID-19, impacting the quality of science and effectiveness of the responses deployed. To galvanise change by strengthening evidence-informed inclusion of sex and gender in COVID-19 practice, we led a virtual collaboration to articulate and prioritise gender and COVID-19 research needs. In addition to standard prioritisation surveys, feminist principles mindful of intersectional power dynamics underpinned how we reviewed research gaps, framed research questions and discussed emergent findings. The collaborative research agenda-setting exercise engaged over 900 participants primarily from low/middle-income countries in varied activities. The top 21 research questions included the importance of the needs of pregnant and lactating women and information systems that enable sex-disaggregated analysis. Gender and intersectional aspects to improving vaccine uptake, access to health services, measures against gender-based violence and integrating gender in health systems were also prioritised. These priorities are shaped by more inclusive ways of working, which are critical for global health as it faces further uncertainties in the aftermath of COVID-19. It remains imperative to address the basics in gender and health (sex-disaggregated data and sex-specific needs) and also advance transformational goals to advance gender justice across health and social policies, including those related to global research.


  • Open Access

    Resolving sex and gender bias in COVID-19 vaccines R&D and beyond

    by Lavanya Vijayasingham, Shirin Heidari, Jean Munro, Saad Omer, Noni MacDonald

    The influence of sex and gender in immune response and vaccine outcomes is established in many disease areas, including in COVID-19. Yet, there are notable gaps in the consideration of sex and gender in the analysis and reporting of COVID-19 vaccines clinical trial data. The push for stronger sex and gender integration in vaccines science should be championed by all researchers and stakeholders across the R&D and access ecosystem – not just gender experts. This requires joint action on the tactical framing of customized value propositions (based on stakeholder motivations), the stronger enforcement of existing regulation, tools, and commitments, and aligning the overall agenda to parallel calls on intersectionality, equity diversity and inclusion.


  • Sex-disaggregated data in COVID-19 vaccine trials

    by Lavanya Vijayasingham, Evelyne Bischof, Jeannette Wolfe